Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Shift4 Payments (FOUR-PA) EBITDA (2019 - 2026)

Shift4 Payments filings provide 7 years of EBITDA readings, the most recent being $148.8 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 47.33% to $148.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $410.7 million, a 46.68% increase, with the full-year FY2025 number at $425.0 million, up 41.2% from a year prior.
  • EBITDA hit $148.8 million in Q4 2025 for Shift4 Payments, up from $119.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $148.8 million in Q4 2025 to a low of -$42.3 million in Q1 2021.
  • Median EBITDA over the past 5 years was $41.9 million (2023), compared with a mean of $44.6 million.
  • Biggest five-year swings in EBITDA: crashed 570.0% in 2021 and later soared 1439.02% in 2022.
  • Shift4 Payments' EBITDA stood at -$3.7 million in 2021, then surged by 440.54% to $12.6 million in 2022, then surged by 353.17% to $57.1 million in 2023, then soared by 76.88% to $101.0 million in 2024, then surged by 47.33% to $148.8 million in 2025.
  • The last three reported values for EBITDA were $148.8 million (Q4 2025), $119.7 million (Q3 2025), and $100.5 million (Q2 2025) per Business Quant data.